Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Wed, 28.07.2021
Cryptology Asset Group PLC
Cryptology share split in a ratio of 1:20 executed; price target increased
to (after split) EUR18.35; Rating: Buy
Cryptology Asset Group plc (Cryptology for short) has completed the
previously announced 1:20 share split as of July 27, 2021. The resolution
for the share split was approved by shareholders at an extraordinary
general meeting on Jul [ … ]
Tue, 20.07.2021
MagForce AG
- Approval for prostate treatment imminent,
- New treatment devices to be installed in Europe,
- Strong growth and break-even expected from 2022 onwards
Despite pandemic-related restrictions, MagForce AG made further progress in
2020 in the commercialisation of its own technology. For the alreadyapproved
treatment of malignant brain tumours in [ … ]
Wed, 07.07.2021
Media and Games Invest SE
MGI raises revenue and earnings forecast for the current financial year due
to very strong organic growth in H1; Planned Smaato acquisition opens up
additional revenue and earnings potential for H2; Increase of our previous
estimates and price target
Guidance increase for the 2021 business year
On 30 June 2021, Media and Games Invest SE (MGI) [ … ]
Tue, 06.07.2021
Cryptology Asset Group PLC
'Leading European investment firm for crypto assets and blockchain
companies.'
'Strong holdings offer high upside potential.'
Cryptology Asset Group plc was founded in January 2018 by Christian
Angermayer's family office, Apeiron Investment Group Ltd, crypto legend
Mike Novogratz and Joram Voelklein. This Malta-based investment company
focuses [ … ]
Wed, 23.06.2021
Cardiol Therapeutics
One Product in two formulations, heart disease treatments in the making
Cardiol Therapeutics provides leadership in therapeutic trials using
Cannabidiol to take advantage of major opportunities in inflammatory heart
disease.
The company has an exclusive manufacturing agreement for a Cannabidiol
pharmaceutical formulation which is highly concen [ … ]
Tue, 15.06.2021
Media and Games Invest SE
Record financial year 2020 concluded with strong profitable growth in
turnover; Another significant increase in turnover and earnings expected
for the current financial year 2021; The growth course we have embarked
upon should lead to a disproportionately high increase in earnings as a
result of economies of scale; Target price: EUR 6.92; Rating: [ … ]
Tue, 08.06.2021
Saturn Oil & Gas Inc.
Saturn Oil & Gas Inc. successfully closes the acquisition of the Oxbow
Assets
Saturn Oil & Gas Inc. announced that it has successfully closed the
previously announced transformational acquisition of the Oxbow assets in
Southeast Saskatchewan from Crescent Point Energy Corp. As discussed in our
recent Transaction Update (http://www.more-i [ … ]
Mon, 07.06.2021
Aves One AG
Concentration on high-margin areas after sale of the maritime container
segment; business development to be even more stable; target price raised
slightly
On 18 March 2021, Aves One AG announced the sale of its sea container
business, which means that the company's focus in future will be on the two
business segments 'rail' and 'swap bodies'. W [ … ]
Wed, 26.05.2021
Aspermont Limited
Aspermont is the leading media services provider to the global resource
industries. Aspermont has invested 20 years in building a commercial model
for B2B media that is founded on providing high value content to a
globalsubscriber base. Aspermont is scaling this B2B model to serve new
sectors and new countries and in new languages to maintain glob [ … ]
Fri, 21.05.2021
Saturn Oil & Gas Inc.
Transformative transaction increasing oil production from 350 boe/d to over
7,200
Prime assets with proven low depletion rates. The company is cur-rently
completing the Oxbow assets acquisition, which is located in the Williston
Basin oil field. The company's new inventory will consist of low decline
oil wells with very low gas volumes (5%), thu [ … ]